Aripiprazole is an atypical antipsychotic drug. Aripiprazole has found widespread use in psychiatry, especially in schizophrenia,bipolar disorder,depression, schizoaffective disorder and obsessive compulsive disorder.Aripiprazole has been known as a weight neutral atypical antipsychotic.This case report examines the treatment and progression of a 16-year-old male with BPAD who experienced substantial weight gain while receiving aripiprazole monotherapy.This report emphasizes the importance of closely monitoring weight-related side effects in patients receiving aripiprazole treatment,particularly within the adolescent demographic.
No takes yet. Share an insight, caveat, or question.
Singhal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: